Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...

The arrival of spring is traditionally associated with allergies, but the crisp air brought on by autumn’s cooler weather doesn’t necessarily mean everyone can take a breath of relief.

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...

The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...

A panel last year said it found evidence the ingredient, used in many popular medicines, did not aid with nasal congestion.

Yesterday, US health officials proposed getting rid of oral drugs containing the decongestant phenylephrine over concerns ...

Share on Facebook Share on Twitter The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the ...

The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency says a common ingredient they share, phenylephrine, doesn’t actually relieve ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...